Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prospective SAJAC Study of Rehabilitation for Adolescents and Young Adults with Cancer in a Comprehensive Cancer Center.

Journal of adolescent and young adult oncology·2026
Same author

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

Nature communications·2026
Same author

NOXA/MCL-1 axis determines cell-death decision between apoptosis and a GSDME-dependent cell death associated with production of inflammatory cytokines upon treatment of breast cancer cells with antimitotics.

Cell death & disease·2026
Same author

Navigating first- and second-line treatment options in HR+HER2-negative advanced breast cancer.

The oncologist·2026
Same author

When effective anticancer therapies are, in fact, destabilizing the tumor's Group Phenotypic Composition.

NPJ precision oncology·2026
Same author

Technical recommendations from a large-scale French Delphi consensus: A step toward European harmonization of ctDNA analysis.

European journal of cancer (Oxford, England : 1990)·2026

相关实验视频

Updated: Jun 3, 2025

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.0K

学习训练和解释一个深度生存模型与大规模的卵巢癌转录组数据.

Elena Spirina Menand1,2, Manon De Vries-Brilland2,3, Leslie Tessier2

  • 1Laboratoire Angevin de Recherche en Ingénierie des Systèmes (EA7315), Université d'Angers, 49035 Angers, France.

Biomedicines
|January 8, 2025
PubMed
概括
此摘要是机器生成的。

深度学习模型使用基因表达数据预测卵巢癌的生存率. 这些模型识别了分子途径,将患者分为高风险和低风险组,帮助个性化治疗策略.

关键词:
在RNA-seqqq.在TCGA中,TCGA就是TCGA.深度学习是一种深度学习.分子路径的分子路径.卵巢癌是发生在卵巢的癌症.生存分析,生存分析.

更多相关视频

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.9K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.6K

相关实验视频

Last Updated: Jun 3, 2025

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.0K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.9K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.6K

科学领域:

  • 在瘤学瘤学.
  • 基因组学就是基因组学.
  • 生物信息学是一种生物信息学.

背景情况:

  • 卵巢癌在全球范围内呈现出糟糕的结果和有限的治疗选择.
  • 新型生物标志物对于分层患者和预测治疗反应至关重要.
  • 基因表达数据为开发预测结果模型提供了潜力.

研究的目的:

  • 利用卵巢癌基因表达数据开发基于深度学习的结果预测器.
  • 确定与患者存活相关的分子途径.
  • 将卵巢癌患者分为不同的风险组进行个性化治疗.

主要方法:

  • 使用了癌症基因组图谱 (TCGA) 卵巢癌转录组数据 (372名患者,约16600个基因).
  • 训练并评估深度学习生存模型.
  • 解释模型输出来导出基因贡献和分子途径.
  • 在内部 (12名患者) 和外部 (274名患者) 数据集上进行了基于途径的验证分层.

主要成果:

  • 确定了使TCGA患者分为高风险和低风险组分层的分子途径 (p=0.025).
  • 在内部数据集 (p=0.229) 和外部数据集 (p=0.006) 上验证了分层有效性.
  • 证明了深度学习模型的可解释性,以揭示与生存相关的生物过程.

结论:

  • 分析RNA-seq数据的深度学习模型可以预测卵巢癌患者的生存率.
  • 这些模型有效地检测和解释与生存结果相关的基因组.
  • 这种方法为生物标志物发现和卵巢癌的个性化治疗提供了新的途径.